{"product_id":"eloralintide","title":"Eloralintide","description":"\u003ch2\u003eELORALINTIDE (LY3841136)\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eSelective Amylin Receptor Agonist | Metabolic \u0026amp; Weight-Management Research\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEloralintide, also known as \u003cstrong\u003eLY3841136\u003c\/strong\u003e, is an investigational long-acting peptide designed to selectively activate the \u003cstrong\u003eamylin-1 receptor (AMY1R)\u003c\/strong\u003e. It is being studied for its effects on appetite regulation, satiety, energy intake, body weight, and metabolic health.\u003c\/p\u003e\n\u003cp\u003eUnlike GLP-1 receptor agonists, Eloralintide works primarily through the \u003cstrong\u003eamylin signaling pathway\u003c\/strong\u003e, making it particularly interesting for research involving alternative or complementary mechanisms of metabolic regulation.\u003c\/p\u003e\n\u003ch3\u003eAreas of Research\u003c\/h3\u003e\n\u003cp\u003e• Appetite and satiety signaling\u003cbr\u003e • Reduced caloric intake\u003cbr\u003e • Body-weight and fat-mass regulation\u003cbr\u003e • Metabolic health\u003cbr\u003e • Amylin-receptor signaling\u003cbr\u003e • Combination research with incretin-based compounds\u003c\/p\u003e\n\u003ch3\u003eResearch Dosing Studied\u003c\/h3\u003e\n\u003cp\u003eHuman clinical research has evaluated \u003cstrong\u003eonce-weekly subcutaneous administration\u003c\/strong\u003e. Phase 2 research included weekly target doses of \u003cstrong\u003e1 mg, 3 mg, 6 mg, and 9 mg\u003c\/strong\u003e, as well as dose-escalation protocols progressing to 9 mg.\u003c\/p\u003e\n\u003ch3\u003eWhy Researchers Are Interested\u003c\/h3\u003e\n\u003cp\u003eEloralintide preferentially activates AMY1R compared with the calcitonin receptor and AMY3R. Early clinical research has demonstrated reductions in body weight and food intake, supporting continued investigation of selective amylin signaling as a distinct approach to metabolic research.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eResearch Use Only\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEloralintide remains an investigational compound and has not been approved as a medication for general clinical use. Research protocols should be based on appropriate published literature and applicable laboratory standards.\u003c\/p\u003e","brand":"Research Peptide Market","offers":[{"title":"5mg","offer_id":44365848346702,"sku":null,"price":0.0,"currency_code":"USD","in_stock":false}],"url":"https:\/\/researchpeptidemarket.com\/products\/eloralintide","provider":"Research Peptide Market","version":"1.0","type":"link"}